Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05081011 · ClinicalTrials.gov registry record · NA
Managing Insulin With a Voice AI
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT05081011: Completed NA study, sponsored by Stanford University.
NCT05081011 is a NA study that has completed, run by Stanford University. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05081011, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
This study randomizes participants to have their basal insulin titrated either through standard of care or by receiving prompts through interactions with an AI-enabled smart speaker device. The primary objective of this study is to investigate the feasibility of an AI-enabled smart speaker device and whether such a device facilitates insulin titration management, increases insulin adherence and decreases time to optimal insulin dose. The secondary objective of the study is to explore whether the device improves glycemic control as defined by improvements in fasting blood sugar.
Interventions
- DEVICE Voice Assistant Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2021-03-24 |
| Est. Completion | 2022-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05081011
The ClinicalTrials.gov registry entry for NCT05081011 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Voice Assistant Device is the first listed.
NCT05081011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05081011 about?
NCT05081011 is a clinical study titled "Managing Insulin With a Voice AI". This study randomizes participants to have their basal insulin titrated either through standard of care or by receiving prompts through interactions with an AI-enabled smart speaker device. The primary objective of this study is to investigate the feasibility of an AI-enabled smart speaker device an...
What is the current status of trial NCT05081011?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2021-03-24. Estimated completion is 2022-12-01.
What interventions are being tested in trial NCT05081011?
The interventions under investigation include: Voice Assistant Device (DEVICE).
Who is sponsoring clinical trial NCT05081011?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.